Eyeing Up New Market Growth: Novel Drugs for Glaucoma Come into Focus

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.7, 2005-01, pp. : 8-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New therapies for glaucoma: are they all up to the task?

By Yorio Thomas Dibas Adnan

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1743-1762

Informa Healthcare

Access to resources Recommend Favorite

Serotonin-Dopamine Interaction as a Focus of Novel Antidepressant Drugs

Current Drug Targets, Vol. 7, Iss. 2, 2006-02 ,pp. : 177-185

Bentham Science Publishers

Access to resources Recommend Favorite

Focus on New Drugs in Development Against Human Cytomegalovirus

By Emery V.C. Hassan-Walker A.F.

Drugs, Vol. 62, Iss. 13, 2002-01 ,pp. : 1853-1858

Adis International

Access to resources Recommend Favorite

Volume and market share of anti-epileptic drugs in the Netherlands: impact of new drugs

By Knoester Pieter Deckers Charles Vaart Ronald Leufkens Bert Hekster Yechiel

Pharmacy World and Science, Vol. 27, Iss. 2, 2005-04 ,pp. : 129-134

Springer Publishing Company

Access to resources Recommend Favorite

New drugs for chemotherapy-induced nausea and vomiting: focus on palonosetron

By Tonini Giuseppe Vincenzi Bruno Santini Daniele

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 1, 2005-06 ,pp. : 143-149

Informa Healthcare

Access to resources Recommend Favorite